Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-03-03FDA Approved: PREMARIN — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Premarin (conjugated estrogens) from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
-
FDA approval · 2008-02-28FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
-
FDA approval · 2008-02-06FDA Approved: ALENDRONATE SODIUM — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the original ANDA for Alendronate Sodium (generic) from Amneal Pharmaceuticals of New York LLC, expanding access for treatment …
-
CLINICAL_TRIALS trial_result · 2008-01-24Clinical Trial Update: Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause [Phase 2]
A Phase 2 clinical trial evaluating natto supplementation to prevent loss of bone mass in women soon after menopause has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy [Phase 2]
Phase 2 study evaluating tibolone for effects on bone density, menopausal symptoms, and breast density in women after prophylactic oophorect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-12-20Clinical Trial Update: Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis. [Phase 2]
Phase 2 trial update evaluating the dose-response of bazedoxifene in Japanese patients with postmenopausal osteoporosis.
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: Satisfaction and Compliance of Risedronate in PMO [Phase 4]
Phase 4 clinical trial update evaluating satisfaction and adherence to risedronate in postmenopausal osteoporosis.
-
CLINICAL_TRIALS trial_result · 2007-10-12Clinical Trial Update: Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 trial comparing medications for osteoporosis in postmenopausal women has completed. This update does not include trial results in th…
-
CLINICAL_TRIALS trial_result · 2007-10-12Clinical Trial Update: A Study of the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 trial update for the treatment of osteoporosis in postmenopausal women. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2007-10-12Clinical Trial Update: PTH Comparison in Post Menopausal Women [Phase 3]
Phase 3 clinical trial comparing parathyroid hormone therapy in postmenopausal osteoporosis has completed.
-
FDA approval · 2007-10-11FDA Approved: DELESTROGEN — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for Delestrogen (estradiol valerate) from Par Health USA, LLC, resulting in updated labeling for…
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Long Term Effects of Raloxifene Treatment on Bone Quality [Phase 4]
Phase 4 trial evaluating the long-term effects of raloxifene on bone quality in postmenopausal osteoporosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo [Phase 4]
Phase 4 trial comparing raloxifene to placebo in postmenopausal osteoporosis assessed carotid artery intima-media thickness; the study has c…
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis [Phase 4]
This update reports results from a Phase 4 trial evaluating bone marker changes in postmenopausal osteoporosis treated with teriparatide. Th…
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]
A Phase 3 clinical trial evaluating teriparatide for postmenopausal osteoporosis has completed. The study was sponsored by Eli Lilly and Com…
-
CLINICAL_TRIALS trial_result · 2007-07-16Clinical Trial Update: 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis [Phase 4]
This Phase 4 trial compares two years of teriparatide therapy to one year of teriparatide followed by one year of raloxifene or calcium/vita…
-
CLINICAL_TRIALS trial_result · 2007-06-12Clinical Trial Update: Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial [Phase 4]
A Phase 4 head-to-head trial comparing teriparatide with strontium ranelate in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-11Clinical Trial Update: Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation. [Phase 1]
Phase 1 bioequivalence study comparing two new Premarin/medroxyprogesterone acetate formulations with the reference Premarin/MPA product; st…
-
CLINICAL_TRIALS trial_result · 2007-05-28Clinical Trial Update: Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women [Phase 1]
Phase 1 study evaluating how water and food intake affect the pharmacokinetics and pharmacodynamics of oral salmon calcitonin in postmenopau…
-
CLINICAL_TRIALS trial_result · 2007-05-25Clinical Trial Update: Effects of Teriparatide in Postmenopausal Women With Osteoporosis [Phase 4]
Phase 4 clinical trial assessing the effects of teriparatide in postmenopausal osteoporosis has been completed.
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis [Phase 4]
A Phase 4 trial evaluated sequential teriparatide followed by raloxifene for postmenopausal osteoporosis; the study has completed.
-
FDA approval · 2007-04-26FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for FOSAMAX PLUS D (alendronate sodium and cholecalciferol) submitted by Organon LLC. This appro…
-
FDA approval · 2007-04-16FDA Approved: RECLAST — Original Application (Sandoz Inc)
FDA approves Sandoz's RECLAST (zoledronic acid) original application for osteoporosis-related indications, including postmenopausal osteopor…
-
FDA label_change · 2007-03-28FDA Approved: MENOSTAR — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA page indicates a supplemental application for Menostar (estradiol) by Bayer HealthCare Pharmaceuticals Inc., likely seeking changes to t…
-
CLINICAL_TRIALS trial_result · 2007-03-09Clinical Trial Update: Effects of Arzoxifene on Bone Mass and the Uterus [Phase 3]
A Phase 3 trial evaluating arzoxifene's effects on bone mass and uterine outcomes in postmenopausal bone loss has completed.